| 2017 | 2016 | |||||||
| U.S loss | $ | (5,419 | ) | $ | (600 | ) | ||
| Non-U.S. income | 162 | 236 | ||||||
| Loss before income taxes | $ | (5,257 | ) | $ | (364 | ) | ||
| 2017 | 2016 | |||||||
| U.S Federal income tax (expense) benefit | ||||||||
| Current | $ | 73 | $ | - | ||||
| Deferred | (13,830 | ) | 157 | |||||
| Total U.S. Federal income tax (expense) benefit | (13,757 | ) | 157 | |||||
| State and local income tax (expense) benefit | ||||||||
| Current | (45 | ) | (58 | ) | ||||
| Deferred | (1,560 | ) | 83 | |||||
| Total state and local income tax (expense) benefit | (1,605 | ) | 25 | |||||
| Foreign income tax (expense) benefit | ||||||||
| Current | (88 | ) | (40 | ) | ||||
| Total income tax (expense) benefit | $ | (15,450 | ) | $ | 142 | |||
| 2017 | 2016 | |||||||
| Valuation allowance at the Beginning of Period | $ | - | $ | - | ||||
| Income tax expense | (11,435 | ) | - | |||||
| Release of valuation allowance | - | - | ||||||
| Valuation allowance at the End of Period | $ | (11,435 | ) | $ | - | |||
| 2017 | 2016 | |||||||
| Income tax expense at the statutory rate | 34.00 | % | 34.00 | % | ||||
| State and local income tax expense | 4.60 | % | 9.16 | % | ||||
| Foreign income tax | (1.17 | %) | (3.79 | %) | ||||
| Permanent differences | (8.25 | %) | (38.40 | %) | ||||
| Research & development credits | 0.00 | % | 37.81 | % | ||||
| Increase in valuation allowance | (217.49 | %) | 0.00 | % | ||||
| Impacts related to the 2017 Tax Act | (105.95 | %) | 0.00 | % | ||||
| Other adjustments | 0.37 | % | 0.31 | % | ||||
| Effective income tax rate | (293.89 | %) | 39.09 | % | ||||
| 2017 | 2016 | |||||||
| Deferred Federal tax assets – | ||||||||
| Bad debt reserves | $ | 1,375 | $ | 1,710 | ||||
| Stock based compensation | 305 | 668 | ||||||
| Net operating loss | 7,319 | 8,184 | ||||||
| Accrued compensation | 249 | 280 | ||||||
| Alternative minimum tax credit | - | 73 | ||||||
| Inventories | 18 | 69 | ||||||
| Accrued rent | 30 | 46 | ||||||
| Goodwill and intangible assets | 3,323 | 6,675 | ||||||
| Research & development credits | 533 | 534 | ||||||
| Other credits | 5 | 5 | ||||||
| Other | 103 | 189 | ||||||
| Total deferred Federal tax assets | 13,260 | 18,433 | ||||||
| Less: valuation allowance | (9,599 | ) | - | |||||
| Net deferred tax assets | 3,661 | 18,433 | ||||||
| Deferred Federal tax liabilities – | ||||||||
| Depreciation and asset basis differences | (3,672 | ) | (4,725 | ) | ||||
| Other | (51 | ) | (157 | ) | ||||
| Total deferred Federal tax liabilities | (3,723 | ) | (4,882 | ) | ||||
| Net deferred Federal tax assets | (62 | ) | 13,551 | |||||
| Net deferred state and local tax assets | 1,836 | 1,560 | ||||||
| Less: valuation allowance | (1,836 | ) | - | |||||
| Net deferred tax (liabilities) assets | $ | (62 | ) | $ | 15,111 | |||